TERAZOSIN HYDROCHLORIDE
NDC 24689-004, terazosin hydrochloride, capsule, from Apnar Pharma LP.
- Product NDC
- 24689-004
- Status
- Listed
- Labeler
- Apnar Pharma LP
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074823
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24689-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE10 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24689-004-01 | 24689000401 | 100 CAPSULE in 1 BOTTLE (24689-004-01) |
| 24689-004-10 | 24689000410 | 1000 CAPSULE in 1 BOTTLE (24689-004-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/619dd5cb-46fb-4ad9-a05f-f064261a636b
Use it
Look up 24689-004 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24689-004 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24689-004. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.